Title : 
 Description : 
 Keywords : 
 Author : Unknown

-----------------------------------------------
Resolution No. 2/99-3  

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES VACCINES FOR CHILDREN PROGRAM


        VACCINES TO PREVENT HAEMOPHILUS INFLUENZAE TYPE B The purpose of this resolution is to consolidate all of the previous resolutions pertaining to Haemophilus influenzae type b vaccine into a single resolution.  This resolution does not make any substantive changes to any of those previous resolutions, except the following:
1. Clarifies catch-up vaccination.
2. Clarifies interchangeability. VFC resolutions 2/94-5, 2/94-6, 6/94-10  and 6/94-14 are repealed and replaced by the following:
Haemophilus influenzae type b





Eligible Groups


Recommended Haemophilus influenzae type b Vaccine Schedule

All children who are 6 weeks of age through 5 years of age.


The recom
   recommended schedule for children includes 3 or 4 doses of a Hib containing vaccine by age 2 yearsmended schedule for children includes 3 or 4 doses of a Hib containing vaccine by age 2 years,, depending on the specific vaccine. The Hib doses should be given at the following ages:
Schedule A               Schedule B
                 2 months 2 months 4 months 4 months 6 months 12-15 months - Booster 12-15 months - Booster Schedule A should be used for the following vaccines: HibTiter, ACTHib, Tetramune, or other Hib vaccines containing HbOC or PRP-T.   Schedule B should be used for the following vaccines: PedvaxHib, Comvax, or other Hib vaccines containing PRP-OMP. The Hib products approved for infant vaccination are considered interchangeable for primary as well as booster vaccination. However, mixed vaccine sequences in the primary series should follow schedule A.  NOTE: Use of brand names is not meant to preclude the use of other licensed Hib vaccines. Catch-Up Vaccination
The ACIP recommends Haemophilus influenzae type b vaccine for all children through 5 years of age. If Hib vaccination is not initiated by 6 months of age, use the following schedule: 
Age (months) at first vaccination Primary series Booster 7-11 2 doses, 2 mos apart 12-18 mos 12-14 1 dose 2 mos later
15-59 1 dose     ----


Page 1 of  3


-----------------------------------------------
Resolution No. 2/99-3  




Dosage Intervals





Schedule Minimum
Age Minimum interval from dose 1 to 2 Minimum interval from dose 2 to 3
Minimum interval from dose 3 to 4

A 6 weeks 1 month 1 month 

B 6 weeks 1 month 

 The booster dose of Hib vaccine which is recommended following the primary vaccination series should be administered no earlier than 12 months of age and at least 2 months after the previous dose of Hib vaccine.

The combined hepatitis B/Hib vaccine may be used whenever administration of any components of the combination are indicated and if other components are not contraindicated; or the separate Hib and hepatitis B vaccines may be used.




Recommended Dosages

Contraindications and Precautions


The following conditions are contraindications to the administration of Haemophilus influenzae type b vaccine:

1. Allergy to vaccine components Anaphylactic reaction to the vaccine or a constituent of the vaccine.

2. Acute, moderate or severe illnesses with or without fever
Refer to product package inserts.





Page 2 of  3


-----------------------------------------------
Resolution No. 2/99-3  

Adopted and Effective: February 18, 1999



http://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/299hib.txt

Page 3 of  3